Search Within

Alexander Noor Shoushtari

  1. "Adam Schoenfeld"
Formats
  1. Meeting Abstract (5)
  2. Research Letter (1)
Groups
  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (6)
  3. Hematology-Oncology Fellows (6)
  4. Melanoma Disease Management Team (6)
  5. Melanoma and Immunotherapeutics Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Adam Schoenfeld (6)
  2. Katherine Panageas (3)
  3. James Smithy (2)
  4. Michael Postow (2)
  5. Alexander Drilon (1)
  6. Allison Betof Warner (1)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. JAMA Oncology (1)
  3. Journal of Thoracic Oncology (1)
  4. Molecular Therapy (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Medical Association (1)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; Prabhakar, P.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P. N.; Ramsingh, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Warner, A. B.; Smithy, J. W.; Postow, M. A.; Panageas, K.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save